Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Johnson

Showing results (341-350 of 441) with videos related to

Pageof 45
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1989
Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patientsR W Schwartz, N M Logan, P J Johnson, et al.
Gut|December 1, 1978
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinomaS P Kane, I M Murray-Lyon, F J Paradinas, et al.
Digestive Diseases and Sciences|December 1, 1995
A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinomaW Yeo, J Y Sung, S C Ward, et al.
Journal of the American Veterinary Medical Association|February 15, 1988
Incomplete linear tibial fractures in two horsesP J Johnson, R V Allhands, G J Baker, et al.
British Medical Journal (Clinical Research Ed.)|September 25, 1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinomaF J Paradinas, W M Melia, M L Wilkinson, et al.
British Medical Journal|January 28, 1978
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulinP J Johnson, M H Wansbrough-Jones, B Portmann, et al.
Cancer Nursing|December 7, 2005
A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapyS S Mak, C Y Zee, A Molassiotis, et al.
Oncology|November 27, 2001
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinomaT C Poon, A T Chan, B Zee, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomesW Yeo, K K Chan, G Mukwaya, et al.
British Journal of Cancer|February 25, 2009
Modelling prognostic factors in advanced pancreatic cancerD D Stocken, A B Hassan, D G Altman, et al.
Pageof 45

Showing results (341-350 of 441) with videos related to

Sort By:
Pageof 45
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1989
Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patientsR W Schwartz, N M Logan, P J Johnson, et al.
Gut|December 1, 1978
Vitamin B12 binding protein as a tumour marker for hepatocellular carcinomaS P Kane, I M Murray-Lyon, F J Paradinas, et al.
Digestive Diseases and Sciences|December 1, 1995
A prospective study of upper gastrointestinal hemorrhage in patients with hepatocellular carcinomaW Yeo, J Y Sung, S C Ward, et al.
Journal of the American Veterinary Medical Association|February 15, 1988
Incomplete linear tibial fractures in two horsesP J Johnson, R V Allhands, G J Baker, et al.
British Medical Journal (Clinical Research Ed.)|September 25, 1982
High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinomaF J Paradinas, W M Melia, M L Wilkinson, et al.
British Medical Journal|January 28, 1978
Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulinP J Johnson, M H Wansbrough-Jones, B Portmann, et al.
Cancer Nursing|December 7, 2005
A comparison of wound treatments in nasopharyngeal cancer patients receiving radiation therapyS S Mak, C Y Zee, A Molassiotis, et al.
Oncology|November 27, 2001
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinomaT C Poon, A T Chan, B Zee, et al.
Cancer Chemotherapy and Pharmacology|July 21, 1999
Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomesW Yeo, K K Chan, G Mukwaya, et al.
British Journal of Cancer|February 25, 2009
Modelling prognostic factors in advanced pancreatic cancerD D Stocken, A B Hassan, D G Altman, et al.
Pageof 45